Annexin 1-dependent actions of glucocorticoids in the anterior pituitary gland: Roles of the N-terminal domain and protein kinase C

Endocrinology

Volumn 143, Issue 8, 2002, Pages 3060-3070

  John, Christopher ^a   Cover, Patricia ^a   Solito, Egle ^a   Morris, John ^b   Christian, Helen ^b   Flower, Roderick ^c   Buckingham, Julia ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; CORTICOTROPIN; DEXAMETHASONE; FORSKOLIN; GLUCOCORTICOID; LIPOCORTIN 1; LIPOCORTIN 5; PROLACTIN; PROTEIN KINASE C;

ADENOHYPOPHYSIS; AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; CYTOPLASM; DRUG MECHANISM; ENZYME INHIBITION; ENZYME MECHANISM; MALE; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RAT;

EID: 0036328584     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.8.8965     Document Type: Article

References (66)

1. Lipocortin 1: A second messenger of glucocorticoid action in the hypothalamo-pituitary-adrenocortical axis
2. Lipocortins 1, 2 and 5 in the central nervous system and pituitary gland of the rat: Selective induction by dexamethasone of lipocortin 1 in the anterior pituitary gland
3. Lipocortin 1 mediates an early inhibition action of glucocorticoids on the secretion of ACTH by the rat anterior pituitary gland in vitro
4. Lipocortin 1 Annexin 1: A candidate paracrine agent localized in pituitary folliculo-stellate cells
5. Localisation and semi-quantitative measurement of lipocortin 1 in rat anterior pituitary cells by fluorescence-activated cell analysis/sorting and electron microscopy
6. Effects of lipocortin 1 and dexamethasone on the secretion of corticotrophin-releasing factors in the rat: In vitro and in vivo studies
7. Glucocorticoids modulate the cellular disposition of lipocortin 1 in the rat brain in vivo and in vitro
8. Characterisation and localisation of lipocortin 1-binding sites on rat anterior pituitary cells by fluorescence-activated cell analysis/sorting and electron microscopy
9. Dexamethasone suppresses the release of prolactin from the rat anterior pituitary gland by lipocortin 1 dependent and independent mechanisms
10. Annexin 1 (lipocortin 1) mediates the glucocorticoid inhibition of cyclic adenosine 3′,5′-monophosphate-stimulated prolactin secretion
11. An antisense oligodeoxynucleotide to lipocortin 1 reverses the inhibitory actions of dexamethasone on the release of adrenocorticotrophin from rat pituitary tissue in vitro
12. Immunoneutralization of lipocortin 1 reverses the acute inhibitory effects of dexamethasone on the hypothalamo-pituitary-adrenocortical responses to cytokines in the rat in vitro and in vivo
13. Opposing influences of glucocorticoids and interleukin-1β on the secretion of growth hormone and ACTH in the rat in vivo: Role of hypothalamic annexin 1
14. Diversity in the calpactin/lipocortin family
15. New proteins involved in cell regulation by calcium ions and phospholipids
16. Human lipocortin similar to ras gene products
17. Five distinct calcium and phospholipid binding proteins share homology with lipocortin 1
18. Characterization of lipocortin 1 and an immunologically unrelated 33-kDa protein as epidermal growth factor receptor/kinase substrates and phospholipase A2 inhibitors
19. In vitro protein kinase C phosphorylation sites of placental lipocortin
20. Amino-terminal sequence of p36 and associated p10 Identification of the site of tyrosine phosphorylation and homology with S-100
21. A calcium dependent 35 Kd substrate for EGF receptor kinase isolated from normal tissue
22. Phosphorylation of a chromaffin granule-binding protein by protein kinase C
23. Phosphorylation of chromaffin granule-binding protein in stimulated chromaffin cells
24. Isolation of a calcium-dependent 35-kilodalton substrate for the epidermal growth factor receptor/kinase from A-431 cells
25. Epidermal growth factor stimulates the phosphorylation of the calcium-dependent 35,000-Dalton substrate in intact A-431 cells
26. Anti-inflammatory actions of a N-terminal peptide from human lipocortin 1
27. Inhibitory effect of peptides derived from the N-terminus of lipocortin 1 on arachidonic acid release and proliferation in the A549 cell line: Identification of E-Q-E-Y-V as a crucial component
28. Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin III SV40 T large antigen transgenic mice
29. 2+-dependent phospholipid binding and phosphorylation of lipocortin I
30. Phosphorylation of lipocortin 1 by the epidermal growth factor
31. Calcium-dependent and phosphorylation-stimulated proteolysis of lipocortin 1 by an endogenous A431 cell membrane protease
32. Regulation of the chromaffin granule aggregating activity of annexin 1 by phosphorylation
33. Annexin 5 as a potential regulator of annexin 1 phosphorylation by protein kinase C
34. Inhibition of protein kinase C by annexin V
35. Activation of protein kinase C inhibits calcium-activated potassium channels in rat pituitary tumour cells
36. The use of corticotrophin production by adenohypophyseal tissue in vitro for the detection and estimation of potential corticotrophin releasing factors
37. Stress and the neuroendocrine axis: The pivotal role of glucocorticoids and lipocortin 1
38. A radioimmunoassay for rat plasma ACTH
39. Adenosine and its analogue N6-R-phenylisopropyl-adenosine modulate anterior pituitary adenylate cyclase activity and prolactin secretion in the rat
40. Histamine-induced in cyclic AMP levels in bovine adrenal medullary cells
41. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
42. Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1
43. Promoting detachment of neutrophlis adherent to murine postcapillary venules to control inflammation: Effect of lipocortin 1
44. Modulation of the hypothalamo-pituitary-adrenocortical responses to cytokines in the rat by lipocortin 1 and glucocorticoids: A role for lipocortin 1 in the feedback inhibition of CRF-41 release?
45. Protein kinase C contains a pseudosubstrate prototope in its regulatory domain
46. 3 cells
47. Effects of peptide fragments of protein kinase C on isolated rat osteoclasts
48. 2-vitamin D3 on the activation of natural killer cells: Role of protein kinase C and extracellular calcium
49. 2+-dependent phospholipid binding: Vesicle aggregation and membrane fusion by annexins
50. Dexamethasone induces the expression of the mRNA of lipocortin 1 and 2 and the release of lipocortin 1 and 5 in differentiated U-937 cells
51. The influence of corticosteroids on the secretion of corticotrophin and its hypothalamic releasing hormone
52. Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse
53. N-terminal peptide fragments of LC1 inhibit A549 cell growth and block EGF induced stimulation of proliferation
54. Intrapituitary distribution and effects of armexin 5 on prolactin release
55. Annexin V and phospholipid metabolism
56. Steroid effects on secretion from subsets of lactotrophs: Role of folliculo-stellate cells and annexin 1
57. Location of sites in human lipocortin 1 that are phosphorylated by protein tyrosine kinases and protein kinases A and C
58. Dexamethasone and IL-6 modulate the expression and phosphorylation status of annexin 1 (lipocortin 1) in a human folliculo-stellate cell line
59. Isolation of two 67 kDa calcium-binding proteins from lung differing in affinity for phospholipids and in anti-phospholipase A2 activity
60. Corticotropin-releasing factor-induced adrenocorticotropin hormone release and synthesis is blocked by incorporation of the inhibitor of cyclic AMP-dependent protein kinase into anterior pituitary tumor cells by liposomes
61. Liposome delivery of cyclic AMP-dependent protein kinase inhibitor into intact cells: Specific blockade of cyclic AMP-mediated corticotropin release from mouse anterior pituitary tumor cells
62. Molecular mechanisms of corticotropin-releasing factor stimulation of calcium mobilization and adrenocorticotropin release from anterior pituitary tumor cells
63. Vasopresssin potentiates cyclic AMP accumulation and ACTH release induced by corticotropin-releasing factor CRF in rat anterior pituitary cells in culture
64. 2+ dependent membrane fusion
65. Identification of a domain that mediates vesicle aggregation reveals functional diversity of annexin repeats
66. Annexin 1-mediated vesicular aggregation: Mechanism and role in human neutrophils